melanotan ii pharmacokinetics half-life human study Benefits of Melanotan-II (MT-2) |
Description
, 40- , L-
A 2003 randomized controlled trial (N = 78 LOE2a) analyzed daily 4 g LC supplementation for 60 days in patients with midlife HE around 50 years of age
Regulation of the human ascorbate transporter SVCT2 exon 1b gene by zinc-finger transcription factors
Ive heard people say it doesnt work, but its not a Miracle worker you have to work with it
